# Royal Sense (NSE: ROYAL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/ROYAL · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹59 Cr, it ranks 2975th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Distribution.

Its return on equity was 17.7% in FY26. Promoters held 62.24% of the company as of 31 Mar 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹59 Cr |
| ROE | 17.7% (FY26) |
| ROCE | 26.1% (FY26) |
| Debt to equity | 0.32 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹62 Cr | ₹6 Cr |
| FY24 | ₹18 Cr | ₹2 Cr |

## Shareholding (31 Mar 2026)

- Promoters: 62.24%
- Non-institutions: 37.76%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Samrat Pharma](https://app.pivotnow.in/stock/SAMRATPH) | — | ₹61 Cr | — | — |
| [Bacil Pharma](https://app.pivotnow.in/stock/BACPHAR) | — | ₹58 Cr | — | — |
| [Veerhealth Care](https://app.pivotnow.in/stock/VEERHEALTH) | — | ₹58 Cr | — | — |
| [Constronics Inf](https://app.pivotnow.in/stock/CONSTRONIC) | — | ₹57 Cr | — | — |
| [Kabra Drugs](https://app.pivotnow.in/stock/KABRADG) | — | ₹56 Cr | — | — |
| [Bandaram Pharma](https://app.pivotnow.in/stock/BANDARAM) | — | ₹53 Cr | — | — |

## Questions and answers

### What is the market cap of Royal Sense?

Royal Sense's market capitalisation is ₹59 Cr (₹59 Cr) at the 22 Oct 2026 close, ranking 2975th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Royal Sense?

Return on equity was 17.7% in FY26 and return on capital employed was 26.1% in FY26 (consolidated figures).

### Is Royal Sense a debt-free company?

No. Royal Sense's debt-to-equity ratio was 0.32 in FY26, with total debt of ₹1 Cr.

### What is the shareholding pattern of Royal Sense?

As of 31 Mar 2026: promoters 62.24%, non-institutions 37.76%.

### Who are Royal Sense's competitors?

The listed Pharma & Healthcare companies closest to Royal Sense by market cap are Samrat Pharma, Bacil Pharma, Veerhealth Care, Constronics Inf, Kabra Drugs and Bandaram Pharma.

### Is Royal Sense a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Royal Sense's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ROYAL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.